Trellis Research, the state court litigation research and analytics provider, today announced that David Sacks, product visionary and highly respected entrepreneur has joined the Trellis Board of Directors.
“David is widely known in the tech startup space as an entrepreneur's entrepreneur - amazing product vision and instinct for how to run a quickly growing company," said Nicole Clark, Trellis Co-Founder, and CEO. “We're lucky to have David on the board and I'm personally looking forward to learning more from him as an entrepreneur.”
“Trellis has made tremendous strides since graduating from TechStars LA in 2018, shaking up the legal research space and providing litigation professionals with an invaluable service," said Sacks. "I look forward to working with Trellis' talented leadership team to help them capitalize as they expand service to additional states."
Trellis is an AI-powered state trial court research and analytics platform that provides judicial analytics, strategic insights on your opposing counsel and makes state trial court rulings fully searchable for the first time.
About Trellis Research
Trellis Research helps legal practitioners practice more strategically by gaining powerful insights from state trial court records which have historically been inaccessible. Trellis also provides practical judicial biographies as well as actionable analytics on individual judges. Their Motion & Issues section and Ruling Analysis Reports on individual judges help users prepare better filings and make more persuasive oral arguments. Trellis was founded by Nicole Clark, a career litigator alongside Alon Shwartz as co-founder and CPO. Trellis has received funding from well known institutional investors including Craft Ventures, Okapi Venture Capital, Sequoia Scout, Revel Ventures and Intrepid Ventures. Trellis is also a graduate of Techstars LA 2018. For more information, visit trellis.law.
The above review statements are those of the sponsor (Source of content) and do not necessarily reflect the official policy, position or views of the content publisher. The content distribution company is therefore not responsible for the content and its authenticity and legal standing of the above subject matter. Each individual is required to exercise its content when making a purchase from the above offer. The information does not constitute advice or an offer to buy. Any purchase made from the above press release is made at your own risk. Editorial merit of this content is subject to news publisher and its downstream partners. Consult an expert advisor/health and professional advisor before any such purchase. Any purchase made from this link is subject to the final terms and conditions of the website's selling as mentioned in the above as source. The content publisher and its downstream distribution partners do not take any responsibility directly or indirectly. If you have any complaints or copyright issues related to this article, kindly contact the company this news is about.
DISCLAIMER of Liability. IN NO EVENT SHALL OUR PR COMPANY BE LIABLE OR RESPONSIBLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, OR EXEMPLARY DAMAGES OF ANY KIND, INCLUDING WITHOUT LIMITATION, LOST PROFITS OR LOST OPPORTUNITIES, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES IN ADVANCE AND REGARDLESS OF THE CAUSE OF ACTION UPON WHICH ANY SUCH CLAIM IS BASED, INCLUDING, WITHOUT LIMITATION, ANY CLAIM ARISING OUT OF OR IN CONNECTION WITH ANY OF THE CONTENT, INCLUDING, WITHOUT LIMITATION, AUDIO, PHOTOGRAPHS, AND VIDEOS, OR OF THE ACCURACY, RELIABILITY, OR LEGALITY OF ANY STATEMENT MADE IN OR OMITTED FROM ANY advertisement, sponsorship, endorsement, testimonial, opinion, or other product-related or service-related statement or review appearing in the Websites or in ANY post or article distributed via the Websites.
Release ID: 12913